首页> 外国专利> method and kit for determining an individual's risk of developing lung cancer, nucleotide probe and / or primers, nucleic acid microarray, method for selecting compounds that modulate gene expression and / or activity, and evaluation method likely response of an individual to prophylactic or therapeutic treatment

method and kit for determining an individual's risk of developing lung cancer, nucleotide probe and / or primers, nucleic acid microarray, method for selecting compounds that modulate gene expression and / or activity, and evaluation method likely response of an individual to prophylactic or therapeutic treatment

机译:确定个体患肺癌风险的方法和试剂盒,核苷酸探针和/或引物,核酸微阵列,选择调节基因表达和/或活性的化合物的方法以及评估个体对预防或治疗的可能反应的方法

摘要

METHOD AND KIT OF DETERMINING THE RISK OF AN INDIVIDUAL TO DEVELOP LUNG CANCER, NUCLEOTIDE AND / OR INITIATOR PROBE, MICROARRANGEMENT OF COMPOUND SELECTION AND MODULE / EOD GENE MODULE / COMPOUND SELECTION THE PROBILITY OF AN INDIVIDUAL'S RESPONSIBILITY FOR PROPHYLATIC OR THERAPEUTIC TREATMENT. The present invention relates to methods for assessing the risk of developing lung cancer in smokers and non-smokers using genetic polymorphism analysis. The present invention also relates to the use of genetic polymorphisms in assessing an individual's risk of developing lung cancer. Suitable nucleotide probes and primers, kits and microarrays for such evaluation are also provided.
机译:确定个体发展肺癌,核苷酸和/或启动子探针,化合物选择和模块/ EOD基因模块的微排列/复合选择的风险的方法和试剂盒,其针对印度人的反应能力。本发明涉及使用遗传多态性分析评估吸烟者和非吸烟者患肺癌的风险的方法。本发明还涉及遗传多态性在评估个体患肺癌的风险中的用途。还提供了用于这种评估的合适的核苷酸探针和引物,试剂盒和微阵列。

著录项

  • 公开/公告号BRPI0610065A2

    专利类型

  • 公开/公告日2010-05-25

    原文格式PDF

  • 申请/专利权人 SYNERGENZ BIOSCIENCE LIMITED;

    申请/专利号BR2006PI10065

  • 发明设计人 ROBERT PETER YOUNG;

    申请日2006-05-19

  • 分类号C12Q1/68;

  • 国家 BR

  • 入库时间 2022-08-21 18:47:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号